{
    "ticker": "NXLIW",
    "name": "Nexalin Technology, Inc.",
    "description": "Nexalin Technology, Inc. is a pioneering company in the field of mental health technology, specializing in non-invasive therapeutic solutions. Founded with the mission to enhance the quality of life for individuals suffering from various mental health disorders, Nexalin focuses on developing advanced neurostimulation devices that utilize proprietary technology to promote brain health and wellness. The company's flagship product, the Nexalin device, is designed to treat conditions such as anxiety, depression, and insomnia without the side effects commonly associated with pharmaceutical treatments. By harnessing the power of neuromodulation, Nexalin aims to provide patients with effective alternatives that enhance their overall mental well-being. The company is dedicated to research and development, continuously seeking to improve its technologies and expand its offerings to cater to a broader range of mental health issues. Nexalin's commitment to innovation is evident in its collaborations with leading medical professionals and institutions, ensuring that its products are grounded in scientific evidence and clinical efficacy. As mental health awareness grows globally, Nexalin positions itself as a leader in the emerging field of mental health technologies, striving to make a meaningful impact in the lives of individuals seeking relief from mental health challenges.",
    "industry": [
        "Healthcare",
        "Medical Devices"
    ],
    "headquarters": "Houston, Texas, USA",
    "founded": "2013",
    "website": "http://www.nexalin.com",
    "ceo": "James A. B. McGowan",
    "social_media": {
        "twitter": "https://twitter.com/NexalinTech",
        "linkedin": "https://www.linkedin.com/company/nexalin-technology-inc/"
    },
    "investor_relations": "http://www.nexalin.com/investor-relations",
    "key_executives": [
        {
            "name": "James A. B. McGowan",
            "position": "CEO"
        },
        {
            "name": "Robert L. Barlow",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Neurostimulation Devices",
            "products": [
                "Nexalin Device"
            ]
        }
    ],
    "seo": {
        "meta_title": "Nexalin Technology, Inc. | Innovative Mental Health Solutions",
        "meta_description": "Explore Nexalin Technology, Inc., a leader in non-invasive neurostimulation devices aimed at improving mental health. Discover our innovative products and commitment to wellness.",
        "keywords": [
            "Nexalin",
            "Mental Health",
            "Neurostimulation",
            "Therapeutic Solutions",
            "Anxiety Treatment",
            "Depression Treatment"
        ]
    },
    "faq": [
        {
            "question": "What does Nexalin Technology specialize in?",
            "answer": "Nexalin Technology specializes in non-invasive neurostimulation devices for mental health treatment."
        },
        {
            "question": "Who is the CEO of Nexalin Technology?",
            "answer": "James A. B. McGowan is the CEO of Nexalin Technology, Inc."
        },
        {
            "question": "Where is Nexalin Technology headquartered?",
            "answer": "Nexalin Technology is headquartered in Houston, Texas, USA."
        },
        {
            "question": "What products does Nexalin offer?",
            "answer": "Nexalin offers the Nexalin Device, designed for the treatment of anxiety, depression, and insomnia."
        },
        {
            "question": "When was Nexalin Technology founded?",
            "answer": "Nexalin Technology was founded in 2013."
        }
    ],
    "competitors": [
        "APTX",
        "HCI",
        "MDVL"
    ],
    "related_stocks": [
        "AMZN",
        "AAPL",
        "MSFT",
        "GOOGL"
    ]
}